New York State Common Retirement Fund Reduces Stock Holdings in DaVita Inc. (NYSE:DVA)

New York State Common Retirement Fund trimmed its stake in DaVita Inc. (NYSE:DVA) by 3.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,641 shares of the company’s stock after selling 1,707 shares during the period. New York State Common Retirement Fund owned 0.05% of DaVita worth $4,886,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Hanseatic Management Services Inc. bought a new position in shares of DaVita during the 3rd quarter valued at about $36,000. Tacita Capital Inc purchased a new position in shares of DaVita during the third quarter worth approximately $118,000. Federated Hermes Inc. increased its position in shares of DaVita by 1,284.4% during the third quarter. Federated Hermes Inc. now owns 1,246 shares of the company’s stock worth $118,000 after acquiring an additional 1,156 shares during the period. CENTRAL TRUST Co raised its stake in DaVita by 93.3% in the third quarter. CENTRAL TRUST Co now owns 1,448 shares of the company’s stock worth $137,000 after buying an additional 699 shares in the last quarter. Finally, CWM LLC lifted its stake in shares of DaVita by 36.9% during the 4th quarter. CWM LLC now owns 1,537 shares of the company’s stock worth $161,000 after purchasing an additional 414 shares during the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at DaVita

In other news, insider James O. Hearty sold 26,164 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $119.64, for a total value of $3,130,260.96. Following the sale, the insider now owns 20,264 shares in the company, valued at approximately $2,424,384.96. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, COO Michael David Staffieri sold 29,488 shares of DaVita stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $119.81, for a total transaction of $3,532,957.28. Following the sale, the chief operating officer now owns 37,687 shares of the company’s stock, valued at $4,515,279.47. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider James O. Hearty sold 26,164 shares of the company’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $119.64, for a total value of $3,130,260.96. Following the completion of the sale, the insider now owns 20,264 shares of the company’s stock, valued at approximately $2,424,384.96. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 134,540 shares of company stock valued at $16,551,071. 1.40% of the stock is currently owned by insiders.

DaVita Stock Performance

NYSE DVA opened at $134.45 on Friday. The stock has a market cap of $11.79 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 1.20 and a beta of 1.04. The business has a fifty day moving average of $133.71 and a 200-day moving average of $112.59. DaVita Inc. has a fifty-two week low of $71.51 and a fifty-two week high of $145.04. The company has a quick ratio of 1.13, a current ratio of 1.19 and a debt-to-equity ratio of 6.65.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, May 2nd. The company reported $2.38 EPS for the quarter, topping the consensus estimate of $1.95 by $0.43. DaVita had a return on equity of 66.59% and a net margin of 6.61%. The company had revenue of $3.07 billion during the quarter, compared to analyst estimates of $3.03 billion. During the same period in the prior year, the firm posted $1.58 earnings per share. The firm’s revenue was up 6.9% on a year-over-year basis. As a group, analysts predict that DaVita Inc. will post 9.49 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DVA has been the topic of several recent analyst reports. Barclays initiated coverage on DaVita in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $133.00 target price on the stock. UBS Group boosted their price objective on DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, February 14th. StockNews.com upgraded DaVita from a “buy” rating to a “strong-buy” rating in a research report on Thursday, April 25th. TheStreet upgraded DaVita from a “c+” rating to a “b-” rating in a research report on Wednesday, February 7th. Finally, Truist Financial boosted their price objective on DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a research note on Tuesday, February 20th. Two analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $118.50.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.